Academic literature on the topic 'Soluble CD89'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Soluble CD89.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Soluble CD89":
Launay, Pierre, Béatrice Grossetête, Michelle Arcos-Fajardo, Emmanuelle Gaudin, Sonia P. Torres, Lucie Beaudoin, Natacha Patey-Mariaud de Serre, Agnès Lehuen, and Renato C. Monteiro. "Fcα Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease)." Journal of Experimental Medicine 191, no. 11 (June 6, 1999): 1999–2010. http://dx.doi.org/10.1084/jem.191.11.1999.
van Zandbergen, Ger, Ralf Westerhuis, Ngaisah Klar Mohamad, Jan G. J. van de Winkel, Mohamed R. Daha, and Cees van Kooten. "Crosslinking of the Human Fc Receptor for IgA (FcαRI/CD89) Triggers FcR γ-Chain-Dependent Shedding of Soluble CD89." Journal of Immunology 163, no. 11 (December 1, 1999): 5806–12. http://dx.doi.org/10.4049/jimmunol.163.11.5806.
Esteve Cols, Clara, Freddzia-Amanda Graterol Torres, Bibiana Quirant Sánchez, Helena Marco Rusiñol, Maruja Isabel Navarro Díaz, Jordi Ara del Rey, and Eva Mª Martínez Cáceres. "Immunological Pattern in IgA Nephropathy." International Journal of Molecular Sciences 21, no. 4 (February 18, 2020): 1389. http://dx.doi.org/10.3390/ijms21041389.
Wu, Haiting, Xiaoyan Wang, Zhe Yang, Qing Zhao, Yubing Wen, Xuemei Li, Wei Zhang, and Ruitong Gao. "Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History." Disease Markers 2020 (January 16, 2020): 1–6. http://dx.doi.org/10.1155/2020/8393075.
Cambier, Alexandra, Patrick J. Gleeson, Lilia Abbad, Fanny Canesi, Jennifer da Silva, Julie Bex-Coudrat, Georges Deschênes, et al. "Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy." Kidney International 101, no. 2 (February 2022): 274–87. http://dx.doi.org/10.1016/j.kint.2021.09.023.
Berthelot, Laureline, Thomas Robert, Vincent Vuiblet, Thierry Tabary, Antoine Braconnier, Moustapha Dramé, Olivier Toupance, Philippe Rieu, Renato C. Monteiro, and Fatouma Touré. "Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes." Kidney International 88, no. 4 (October 2015): 815–22. http://dx.doi.org/10.1038/ki.2015.158.
Vuong, Mai T., Mirjana Hahn-Zoric, Sigrid Lundberg, Iva Gunnarsson, Cees van Kooten, Lars Wramner, Maria Seddighzadeh, et al. "Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy." Kidney International 78, no. 12 (December 2010): 1281–87. http://dx.doi.org/10.1038/ki.2010.314.
Hahn-Zoric, Mirjana, Mai Vuong, Sigrid Lundberg, Lars Wramner, Jarl Ahlmen, Lars Å. Hanson, Iva Gunnarsson, Stefan Jacobson, and Leonid Padyukov. "Su.82. Evidence for Genetic Regulation of Fc Alpha Receptor (CD89) Expression: Study of Soluble CD89 in Plasma of IgA Nephropathy Patients and Healthy Controls." Clinical Immunology 127 (January 2008): S151. http://dx.doi.org/10.1016/j.clim.2008.03.433.
Hahn-Zoric, Mirjana, Neda Tahmasebifar, Cees van Kooten, Jarl Ahlmen, Svante Swerkersson, Sverker Hansson, Ulla Berg, Lars Åke Hanson, Leonid Padyukov, and Stefan H. Jacobson. "Immunoassays for Detection of Soluble Fc Alpha Receptor (CD89) in Plasma of IgA Nephropathy Patients." Clinical Immunology 123 (2007): S54—S55. http://dx.doi.org/10.1016/j.clim.2007.03.335.
Berthelot, Laureline, Christina Papista, Thiago T. Maciel, Martine Biarnes-Pelicot, Emilie Tissandie, Pamela H. M. Wang, Houda Tamouza, et al. "Transglutaminase is essential for IgA nephropathy development acting through IgA receptors." Journal of Experimental Medicine 209, no. 4 (March 26, 2012): 793–806. http://dx.doi.org/10.1084/jem.20112005.
Dissertations / Theses on the topic "Soluble CD89":
Staab, Christine [Verfasser], and Lars [Akademischer Betreuer] Nitschke. "Production of Recombinant Human Soluble CD83 in an Eukaryotic System and Generation of Tissue-Specific CD83 Knock-out Mice / Christine Staab. Betreuer: Lars Nitschke." Erlangen : Universitätsbibliothek der Universität Erlangen-Nürnberg, 2011. http://d-nb.info/1015475329/34.
Sanchez, Vidales Maria Del Mar. "Release of Soluble Interleukin-7 α Receptor (CD127) from CD8+ T-Cells and Human Thymocytes." Thesis, Université d'Ottawa / University of Ottawa, 2016. http://hdl.handle.net/10393/34631.
Aloufi, Nawaf. "The role of sCD127 in IL-7-Mediated T Cell Homeostasis in Vivo." Thesis, Université d'Ottawa / University of Ottawa, 2020. http://hdl.handle.net/10393/41089.
Morice, Yoann. "Le virus de l'hépatite C : études de la variabilité inter- et intra-génomique : production sous forme soluble de protéines membranaires impliquées dans l'interaction virus-cellule hôte." Paris 7, 2002. http://www.theses.fr/2002PA077217.
SADAT, SOWTI COMBADIERE BEHAZINE. "Controle des reponses cytotoxiques par les lymphocytes cd8+cd57+ au cours de l'infection par le vih et apres transplanttion de moelle osseuse / caracterisation d'un facteur soluble inhibiteur (icf)." Paris 7, 1993. http://www.theses.fr/1993PA077357.
Kastenmüller, Kathrin [Verfasser], Dirk [Akademischer Betreuer] Busch, Wolfgang [Akademischer Betreuer] Wurst, and Siegfried [Akademischer Betreuer] Scherer. "Generation of CD8+ T cell mediated protective immunity upon vaccination with soluble antigen : involvement of immunmodulatory factors like adjuvant or regulatory lymphocytes / Kathrin Kastenmüller. Gutachter: Wolfgang Wurst ; Siegfried Scherer. Betreuer: Dirk Busch." München : Universitätsbibliothek der TU München, 2006. http://d-nb.info/1058141163/34.
Dioszeghy, Vincent. "Etude des activités antivirales solubles non cytolytiques des lymphocytes CD8+ au cours de l'infection par SIV : Effet d'un traitement par polychimiothérapie post-exposition, effet d'un traitement immuno-modulateur par l'interleukine 2 et mécanismes de reconstitution lymphocytaire T CD4+." Paris 11, 2006. http://www.theses.fr/2006PA11T012.
Müssig, Oliver. "Bedeutung des löslichen CD14-Rezeptors in Plasma und Urin als immunologischer Parameter nach Nierentransplantation und sein Verhältnis zu den löslichen Rezeptoren IL2R, CD4 und CD8." Doctoral thesis, 2011. http://hdl.handle.net/11858/00-1735-0000-0006-B1DF-C.
Berg, Martina [Verfasser]. "Induction of cytotoxic CD8+ T cells by a soluble HLA-derived tumor-associated peptide and regulation of CD8+ T cell activation by CTLA-4 / vorgelegt von Martina Berg." 2005. http://d-nb.info/977277305/34.
DI, FILIPPO ALESSANDRA. "Immune profile of cancer patients to improve selection and efficacy of immunotherapeutic strategies." Doctoral thesis, 2022. https://hdl.handle.net/11573/1665638.
Book chapters on the topic "Soluble CD89":
Lusso, Paolo. "Suppression of Primate Immunodeficiency Lentiretroviruses by CD8+ T-Cell-Derived Soluble Factors." In AIDS Pathogenesis, 133–53. Dordrecht: Springer Netherlands, 2000. http://dx.doi.org/10.1007/978-94-017-0685-8_8.
Weiss, C., S. Hohaus, E. Ogniben, M. Dörner, and R. Haas. "Effect of Recombinant Human Granulocyte—Macrophage Colony-Stimulating Factor on Serum Levels of Soluble CD25, CD8, and CD4 in Patients with Hodgkin’s Disease in Sensitive Relapse." In Cytokines in Hemopoiesis, Oncology, and AIDS II, 587–93. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-48715-6_74.
Bayhan, Ülkü, and Remziye Banka. "Nobel Molecule Artemisia-Annua and T-CD8+ Receptor Bestfit Interactions." In Matematik ve Fen Bilimleri Üzerine Araştırmalar-II. Özgür Yayınları, 2023. http://dx.doi.org/10.58830/ozgur.pub165.c799.
"CD8 Antiviral Soluble Factors and Human Immunodeficiency Virus (HIV) Control." In Soluble Factors Mediating Innate Immune Responses to HIV Infection, edited by Nitin K. Saksena, Jing Qin Wu, Katherine Lau, Li Zhou, Maly Soedjono, and Bin Wang, 1–16. BENTHAM SCIENCE PUBLISHERS, 2012. http://dx.doi.org/10.2174/978160805006211001010001.
Magnin, Morgane, Philippe Guillaume, George Coukos, Alexandre Harari, and Julien Schmidt. "High-throughput identification of human antigen-specific CD8+ and CD4+ T cells using soluble pMHC multimers." In Methods in Enzymology, 21–42. Elsevier, 2020. http://dx.doi.org/10.1016/bs.mie.2019.05.019.
Conference papers on the topic "Soluble CD89":
Soodaeva, Svetlana K., Nailya Kubysheva, Larisa Postnikova, Viktor Novikov, Tatyana Eliseeva, and Igor A. Klimanov. "The level of soluble CD8 molecules in serum and sputum in COPD patients with an exacerbation." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa3653.
Asai, Kazuhisa, Nahoko Shiratsuchi-Nakagawa, Gakuya Tamagaki, Tetsuya Watanabe, Yumiko Imahashi, Yukikazu Ichimaru, Yoshihiro Tochino, Hiroshi Kamoi, Hiroshi Kanazawa, and Kazuto Hirata. "Soluble Perforin, A Marker Of CD8+ T Lymphocyte Activation In Epithelial Lining Fluid In COPD Patients." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4545.
Haile, Samuel, Sonia P. Dalal, Virginia Clements, Koji Tamada, and Suzanne Ostrand-Rosenberg. "Abstract 462: Soluble CD80 restores T-cell activation and overcomes tumor cell programmed death ligand-1-mediated suppression." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-462.
Horn, Lucas, Virginia Clements, and Suzanne Ostrand-Rosenberg. "Abstract B013: A soluble form of CD80 enhances anti-tumor immunity by inhibiting PDL1 immune suppression and does not suppress via CTLA-4." In Abstracts: CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-b013.
Long, Tiha M., and Suzanne Ostrand-Rosenberg. "Abstract B017: A soluble form of CD80 inhibits PD-L1 immune suppression and stimulates T cells through CD28-specific pathways indicating potential for increased therapeutic activity over checkpoint inhibition alone." In Abstracts: CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-b017.
Zhang, Jinyu, Pablo Larrocha, Payal Dhar, and Jennifer Wu. "Abstract A77: Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual costimulation of CD8 T cells and enables sMIC+ tumors to respond to PD1/PD-L1 blockade therapy." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 17-20, 2019; Boston, MA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm19-a77.